Hook and thesis
Tetra Tech (TTEK) looks attractively positioned as a trade today. The company reported a quarter on 11/11/2026 that modestly beat revenue and EPS expectations ($1.15 billion revenue and $0.49 EPS versus consensus $0.47), while delivering strong free cash flow and maintaining conservative leverage metrics. At $38.11, shares are trading near the 20-day moving average and well above the 50-day SMA, leaving room for upside if management continues to convert backlog into revenue and margins expand as execution stabilizes.
We think the next 180 trading days - the period in which backlog conversion and margin expansion should become visible in results and guidance - provide an asymmetric risk/reward. Our actionable plan: buy at $38.11, place a stop at $34.00, and target the 52-week high of $43.14 as the first objective. The trade banks on continued backlog stabilization, improving operating leverage and steady free cash flow generation.
What Tetra Tech does and why the market should care
Tetra Tech is a consulting and engineering firm focused on water, environment, infrastructure, renewable energy and international development. Its two operating groups - Government Services Group (GSG) and Commercial & International Services Group (CIG) - expose the company to relatively stable government spending (domestic and development agencies) and commercial project work tied to infrastructure and environmental remediation.
For investors, the key fundamental driver is backlog conversion and margin recovery. Engineering and professional services businesses can swing quickly when utilization, project mix and contract pricing improve. Tetra Tech's strengths today include a sizable market capitalization near $9.76 billion, a healthy free cash flow run-rate ($548.2 million), and manageable leverage (debt-to-equity ~0.43 and reported net-debt-to-EBITDA commentary in the market that places the company at roughly sub-1x levels). Those metrics give the company room to reinvest, pursue selective M&A, and ride steady government program spending - all supportive of higher valuation if margins continue to expand.
Supporting evidence from the numbers
- Recent quarterly performance: Q3 (reported 11/11/2026) produced $1.15 billion in revenue and $0.49 EPS, beating consensus and showing resilience in top-line demand.
- Profitability and returns: Tetra Tech shows a trailing return on equity of roughly 23.5% and return on assets near 9.94% - indicators the business converts capital into returns efficiently.
- Cash flow and capital structure: Free cash flow sits at $548.2 million and enterprise value is roughly $10.22 billion, implying a FCF yield in the mid-single digits. Debt metrics are conservative - debt-to-equity ~0.43 - leaving balance sheet flexibility.
- Valuation: The stock trades at about 22x reported earnings (P/E ~22.1) and EV/EBITDA near 15.3x. That’s not cheap, but given Tetra Tech’s stable government exposure, improving cash flow and ROE profile, the valuation is reasonable versus the risk of execution missteps.
Valuation framing
Market cap near $9.7-$9.8 billion and EV of roughly $10.22 billion put Tetra Tech in a mid-cap bracket with established government and commercial franchises. P/E ~22x and EV/EBITDA ~15x imply expectations for steady, not spectacular, growth and margin normalization. If management can translate backlog conversion into higher margin projects and maintain or improve the current free cash flow run-rate, the market should re-rate the stock higher. Conversely, if margin erosion recurs, the current multiples will look stretched.
We do not rely on a single multiple target. Instead, this trade targets the 52-week high of $43.14 as the first logical upside: a move there would reflect investors' willingness to pay up for clearer evidence of margin expansion and backlog visibility. The risk/reward from $38.11 to $43.14 is attractive for a 180 trading-day horizon if the company demonstrates the execution we outline below.
Catalysts (what we’re watching)
- Backlog trends and awards: any quarterly commentary or disclosed backlog growth that shows higher visibility into 2027 revenue conversion will be a positive catalyst.
- Margin expansion: sequential improvement in gross and operating margins as higher-margin projects ramp and cost discipline holds.
- Free cash flow and leverage: continued FCF generation and the ability to keep net leverage below 1x EBITDA will support multiple expansion.
- Government and water-related program approvals: incremental program funding or multi-year contract wins in water and environmental services.
- Strategic tuck-ins or efficiency-focused M&A that are immediately accretive to margins and FCF.
Trade plan (actionable)
| Action | Price | Horizon | Rationale |
|---|---|---|---|
| Buy | $38.11 | Long term (180 trading days) | Entry near current level captures upside from backlog conversion and margin expansion while limiting downside exposure. |
| Stop loss | $34.00 | Triggered intra-horizon | Below recent technical support and a clear indication of execution stress if broken. |
| Target | $43.14 | Long term (180 trading days) | Marks the 52-week high and a realistic re-rating level if margins and backlog visibility improve. |
Technical and market context
Technically, the stock sits near its 20-day SMA ($38.76) and above the 50-day SMA ($36.23), with RSI neutral at ~51 and MACD signaling a mildly bearish momentum reading. Short interest has been non-trivial and rising into recent months (settlement data showed ~13.6 million shares on 10/30), which can amplify moves on positive news as shorts cover. Average volume measures indicate institutional liquidity is present, but the two-week average volume shows some variability, so market moves around catalysts could be amplified.
Risks and counterarguments
- Backlog conversion disappoints - If the company struggles to convert its pipeline into revenue at expected margins, earnings and cash flow would lag, pressuring multiples. This is the principal execution risk for any engineering services firm.
- Margin pressure from cost inflation or project mix - Rising input costs or a shift toward lower-margin work could compress operating margins and hurt EPS even if revenue grows.
- Government budget risk - A slowdown or reprioritization of federal/state program funding that impacts water, environmental or international development projects would reduce revenue visibility.
- Short-squeeze vulnerability and flow risk - Elevated short interest can mean volatile moves; a negative print or weak guidance could spark outsized downside.
- Valuation complacency - At ~22x P/E and EV/EBITDA ~15x, the stock already prices a degree of execution; any slippage could force multiple compression.
Counterargument: One could argue that much of the backlog recovery and margin improvement is already priced in. The company is trading at 22x earnings and EV/EBITDA in the mid-teens, and any miss on order awards or guidance could quickly change the narrative. Furthermore, cyclical weakness in commercial spending or slower federal appropriations would reduce the visibility that underpins our target. Those are valid concerns and justify a disciplined stop and a finite horizon for the trade.
What would change my mind
I would abandon this trade if the company posts two consecutive quarters of declining margins or if free cash flow falls materially below the current run-rate of roughly $548 million. A sustained increase in net leverage or a significant write-down/contract remediation event would also move me to sell. On the positive side, a clear acceleration in backlog awards or explicit guidance for higher-margin project mix would prompt me to raise targets and add to the position.
Conclusion
Tetra Tech is an actionable buy at $38.11 for the long-term (180 trading days) trade if you want exposure to an engineering services business with healthy returns metrics, strong free cash flow and conservative leverage. The trade is not without execution risk - backlog conversion and margin stability are the linchpins - but the current price offers reasonable upside to the 52-week high of $43.14 with a clearly defined $34.00 stop. If management can continue to convert work at improving margins while maintaining FCF, the market should be willing to pay a higher multiple. Monitor backlog, margins and FCF closely; those three metrics will tell you if this thesis is playing out.
Trade specifics: Buy at $38.11; Stop $34.00; Target $43.14; Horizon: long term (180 trading days).